| Uniprot ID: | P29279 |
| Secondary ID: | E1P578 |
| Symbol: | CTGF |
| Other Name: | CCN2,CCN family member 2,Hypertrophic chondrocyte-specific protein 24,Insulin-like growth factor-binding protein 8,IBP-8,IGF-binding protein 8,IGFBP-8 |
| Class: | Single Protein |
| Type: | pro-fibrotic |
| Molecular Function: | Heparin-binding |
| Category I | Category II | Category III |
|---|---|---|
| Extracellular | Growth factor and receptor | CTGF family |
Reference Record 1
| PubMed ID | 28287886 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 2
| PubMed ID | 26129822 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | cells proliferation,cells migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 3
| PubMed ID | 27597128 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 4
Reference Record 5
| PubMed ID | 27249027 | Compound ID | |
| CAS | Name | ||
| Model | human | Fibrosis Disease | Scar |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 6
| PubMed ID | 27108403 | Compound ID | |
| CAS | Name | ||
| Model | vitro,rat | Fibrosis Disease | Skin fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 7
| PubMed ID | 25815693 | Compound ID | |
| CAS | Name | ||
| Model | vitro,rat | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | fibroblasts proliferation,fibroblasts differentiation,fibroblasts migration | ||
| Process III | |||
| Mechanism | |||
Reference Record 8
| PubMed ID | 25384022 | Compound ID | |
| CAS | Name | ||
| Model | human | Fibrosis Disease | Peritoneal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 9
| PubMed ID | 25326099 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Skin fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 10
| PubMed ID | 24393160 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Skin fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 11
| PubMed ID | 24282226 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Corneal fibrosis |
| Process I | |||
| Process II | fibroblasts migration | ||
| Process III | |||
| Mechanism | |||
Reference Record 12
| PubMed ID | 24239602 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 13
| PubMed ID | 24074434 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Scar |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 14
| PubMed ID | 23102621 | Compound ID | |
| CAS | Name | ||
| Model | rat | Fibrosis Disease | Pulmonary fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 15
| PubMed ID | 23092863 | Compound ID | |
| CAS | Name | ||
| Model | vitro,rat | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 16
| PubMed ID | 22969957 | Compound ID | |
| CAS | Name | ||
| Model | human | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 17
| PubMed ID | 22329991 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | cells proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 18
| PubMed ID | 21978691 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Systemic sclerosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 19
| PubMed ID | 21747166 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human,mice | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs activation,cells apoptosis | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 20
Reference Record 21
| PubMed ID | 21215756 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 22
| PubMed ID | 20660557 | Compound ID | |
| CAS | Name | ||
| Model | human | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 23
| PubMed ID | 20430035 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 24
| PubMed ID | 20368699 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Pancreatic fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 25
| PubMed ID | 19822645 | Compound ID | |
| CAS | Name | ||
| Model | human | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 26
| PubMed ID | 19641518 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Skin fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TGF-β/Smad/CTGF | ||
Reference Record 27
| PubMed ID | 19565505 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Systemic sclerosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Col1a2 | ||
Reference Record 28
| PubMed ID | 19541844 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | cells proliferation,myofibroblasts differentiation,myofibroblasts accumulation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting CTGF-ILK-Akt pathway | ||
Reference Record 29
| PubMed ID | 18639630 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Pancreatic fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 30
| PubMed ID | 18613219 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs activation,HSCs proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 31
| PubMed ID | 18481257 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Systemic sclerosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 32
| PubMed ID | 18450591 | Compound ID | |
| CAS | Name | ||
| Model | vitro,human,rabbit | Fibrosis Disease | Eye fibrosis |
| Process I | |||
| Process II | cells migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 33
| PubMed ID | 17030714 | Compound ID | |
| CAS | Name | ||
| Model | human | Fibrosis Disease | Eye fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 34
| PubMed ID | 16914537 | Compound ID | |
| CAS | Name | ||
| Model | vitro,rat | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | EMT | ||
| Process III | |||
| Mechanism | |||
Reference Record 35
| PubMed ID | 16889607 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | EMT | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 36
| PubMed ID | 16361307 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Pancreatic fibrosis |
| Process I | |||
| Process II | cells migration | ||
| Process III | |||
| Mechanism | |||
Reference Record 37
| PubMed ID | 15980944 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 38
| PubMed ID | 15870892 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Peritoneal fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 39
| PubMed ID | 15574513 | Compound ID | |
| CAS | Name | ||
| Model | vitro,mice | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | fibroblasts accumulation | ||
| Process III | |||
| Mechanism | |||
Reference Record 40
| PubMed ID | 15566956 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | EMT,myofibroblasts differentiation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 41
| PubMed ID | 15256388 | Compound ID | |
| CAS | Name | ||
| Model | mice | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | myofibroblasts accumulation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 42
| PubMed ID | 15153554 | Compound ID | |
| CAS | Name | ||
| Model | rat | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | myofibroblast differentiation,fibroblasts migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 43
| PubMed ID | 12947014 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 44
| PubMed ID | 12819040 | Compound ID | |
| CAS | Name | ||
| Model | rat | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 45
| PubMed ID | 12819040 | Compound ID | |
| CAS | Name | ||
| Model | rat | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 46
| PubMed ID | 11934704 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 47
Reference Record 48
| PubMed ID | 11934704 | Compound ID | |
| CAS | Name | ||
| Model | vitro,rat | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 49
| PubMed ID | 11576939 | Compound ID | |
| CAS | Name | ||
| Model | vitro | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||